EssilorLuxottica Société anonyme (FRA:ESL)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	117,040	107,377	81,962	75,236	82,608	55,649
Market Cap Growth	17.24%	31.01%	8.94%	-8.92%	48.44%	-5.33%
Enterprise Value	128,885	117,738	92,655	86,453	85,117	60,704
Last Close Price	254.20	231.04	175.38	161.96	175.28	119.49
PE Ratio	49.16	45.52	35.81	34.96	57.05	654.70
PS Ratio	4.30	4.05	3.23	3.07	4.17	3.86
PB Ratio	3.05	2.62	2.11	1.97	2.30	1.70
P/FCF Ratio	34.80	32.03	24.61	23.43	23.50	24.16
P/OCF Ratio	23.82	22.03	16.86	15.73	18.18	18.85
EV/Sales Ratio	4.73	4.44	3.65	3.53	4.29	4.21
EV/EBITDA Ratio	19.47	21.17	17.90	16.91	21.68	29.99
EV/EBIT Ratio	36.43	33.82	29.35	27.75	37.88	136.72
EV/FCF Ratio	38.32	35.13	27.82	26.92	24.22	26.36
Debt / Equity Ratio	0.37	0.32	0.30	0.32	0.36	0.36
Debt / EBITDA Ratio	2.12	2.02	1.91	2.02	2.81	4.58
Debt / FCF Ratio	4.18	3.94	3.50	3.80	3.70	5.17
Asset Turnover	0.44	0.43	0.42	0.41	0.36	0.28
Inventory Turnover	3.27	3.37	3.46	3.49	3.55	3.11
Quick Ratio	0.60	0.58	0.63	0.59	0.70	1.85
Current Ratio	0.97	0.95	1.00	0.97	1.04	2.22
Return on Equity (ROE)	6.44%	6.24%	6.30%	6.16%	4.65%	0.44%
Return on Assets (ROA)	3.58%	3.49%	3.26%	3.25%	2.51%	0.53%
Return on Capital (ROIC)	4.25%	4.15%	3.91%	3.92%	3.00%	0.62%
Return on Capital Employed (ROCE)	7.00%	6.50%	6.20%	6.00%	4.50%	1.00%
Earnings Yield	2.03%	2.20%	2.79%	2.86%	1.75%	0.15%
FCF Yield	2.87%	3.12%	4.06%	4.27%	4.25%	4.14%
Dividend Yield	1.56%	1.71%	2.25%	1.99%	1.43%	1.87%
Payout Ratio	22.97%	49.30%	21.28%	21.10%	9.53%	591.76%
Buyback Yield / Dilution	-1.36%	-2.05%	-1.15%	-0.04%	-1.47%	0.48%
Total Shareholder Return	0.20%	-0.34%	1.11%	1.95%	-0.04%	2.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.